Prevalence of neurocognitive and perceived speech deficits in patients with head and neck cancer before treatment: Associations with demographic, behavioral, and disease-related factors

Background: Neurocognition and speech, relevant domains in head and neck cancer (HNC), may be affected pretreatment. However, the prevalence of pretreatment deficits and their possible concurrent predictors are poorly understood. Methods: Using an …

Assessment of Neurocognitive Impairment and Speech Functioning Before Head and Neck Cancer Treatment

We documented cognitive and speech functioning before treatment in individuals with head and neck cancer in a prospective cohort study. Results indicated a high prevalence of speech and cognitive impairment. Patient-reported speech and cognitive function were associated with each other, whereas objective cognitive measures were not associated with patient-reported measures.